New Jersey Institute of Technology (NJIT) researchers have unveiled a new lab technique they say represents a ‘paradigm shift’ in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.
